STRATA CRITICAL MEDICAL, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $126.00K.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$26.00K, a 966.67% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $3.00K, a 0.00% change year-over-year.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was -$339.00K.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$80.00K.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$66.00K, a 191.67% decline from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was $72.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$339.00K 10-K · filed 2026-03-03 | |||
| 2025-09-30 | -$339.00K 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | $277.00K 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | $126.00K 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$80.00K 10-K · filed 2026-03-03 | |||
| 2024-09-30 | $29.00K 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | -$33.00K 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | -$26.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$66.00K 10-K · filed 2025-03-13 | |||
| 2023-09-30 | -$81.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $20.00K 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $72.00K 10-K · filed 2024-03-12 | |||
| 2022-09-30 | -$9.00K 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $7.00K 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$9.00K 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-10 | $0.00 10-K · filed 2023-03-16 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $0.00 8-K · filed 2023-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |